TMCnet News
Research and Markets: Global Fallopian Tube Cancer Therapeutics Pipeline Review, H2 2015Research and Markets (http://www.researchandmarkets.com/research/nbk95m/fallopian_tube) has announced the addition of the "Fallopian Tube Cancer - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Fallopian Tube Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fallopian Tube Cancer and special features on late-stage and discontinued projects. The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advanage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products. Companies Mentioned - 35 of the 69 Companies Featured
For more information visit http://www.researchandmarkets.com/research/nbk95m/fallopian_tube.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005385/en/ |